Ticker HubNasdaq

UTMD

Utah Medical Products Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Latest price

$66.80-2.96%

As of Oct 29, 2026, 4:01 PM EDT · Market data by Massive

Market cap

$218.6M

Volume

32.6K

Previous close

$68.84

Day range

$66.65 – $69.92

Listed

Dec 1, 1982

Coverage

4 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$74.80$72.75$70.71$68.66$66.62Mon, 10/26Tue, 10/27Wed, 10/28Thu, 10/29Fri, 10/30
Five-day open $74.80Latest interval $68.33

Newsroom

Latest UTMD coverage

SCD
NewsJan 31, 2024

UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance

[ad_1] SALT LAKE CITY, UT – (NewMediaWire) – January 30, 2024 – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved financial results for the full year of 2023 consistent with management’s beginning of year projections.     Currencies in this release are ..

UTMD
SCD
NewsOct 28, 2023

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023

[ad_1] SALT LAKE CITY, UT – (NewMediaWire) – October 26, 2023 – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for nine months (9M) 2023 consistent with those anticipated in its beginning of year projections.  Currencies in this release are denoted as $ or USD = U.S. D

UTMD
SCD
NewsJul 24, 2021

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021

[ad_1] SALT LAKE CITY, UTAH – (NewMediaWire) – July 22, 2021 – The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on

UTMD
SCD
NewsApr 26, 2021

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2021

[ad_1] SALT LAKE CITY, UT – (NewMediaWire) – April 22, 2021 – Because of the aberration in results which began in March 2020 due to the impact of restrictions on “nonessential” medical procedures, Utah Medical Products, Inc. (Nasdaq: UTMD) will report 2021 quarterly income statement results compared to the same periods in both 2020 and ...

UTMD
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.